Sfoglia per Autore
Modeling skeletal dysplasia in Hurler syndrome using patient-derived bone marrow osteoprogenitor cells
2024 Donsante, S; Pievani, A; Palmisano, B; Finamore, M; Fazio, G; Corsi, A; Biondi, A; Tomatsu, S; Piazza, R; Serafini, M; Riminucci, M
CARs are sharpening their weapons
2024 Pievani, A; Biondi, M; Tettamanti, S; Biondi, A; Dotti, G; Serafini, M
First-hit SETBP1 mutations cause a myeloproliferative disorder with bone marrow fibrosis
2024 Crespiatico, I; Zaghi, M; Mastini, C; D'Aliberti, D; Mauri, M; Mercado, C; Fontana, D; Spinelli, S; Crippa, V; Inzoli, E; Manghisi, B; Civettini, I; Ramazzotti, D; Sangiorgio, V; Gengotti, M; Brambilla, V; Aroldi, A; Banfi, F; Barone, C; Orsenigo, R; Riera, L; Riminucci, M; Corsi, A; Breccia, M; Morotti, A; Cilloni, D; Roccaro, A; Sacco, A; Stagno, F; Serafini, M; Mottadelli, F; Cazzaniga, G; Pagni, F; Chiarle, R; Azzoni, E; Sessa, A; Gambacorti Passerini, C; Elli, E; Mologni, L; Piazza, R
Overexpression of CXCR4 receptor on CD33.CAR-CIK cells enhances the control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Biondi, A; Pievani, A; Serafini, M
Acute Myeloid Leukemia (AML) immunotherapy: development of TIM3-CD33 targeted Dual CAR CIK cells for eradication of LSCs in the bone marrow niche
2023 Arsuffi, C; Biondi, A; Tettamanti, S; Serafini, M
Isolation of single circulating trophoblasts from maternal circulation for noninvasive fetal copy number variant profiling
2023 Doffini, A; Forcato, C; Mangano, C; Lattuada, D; Aversa, R; Maranta, C; Giovannone, E; Buson, G; Bolognesi, C; Maiocchi, R; Dori, M; Jamal, L; Ahmad, R; Yeo, G; Yeo, T; Saragozza, S; Silipigni, R; Serafini, M; Biondi, A; Perego, S; Vergani, P; Ferrazzi, E; Ricciardi-Castagnoli, P; Musci, T; Grati, F
IL3-zetakine combined with a CD33 costimulatory receptor as a Dual CAR approach for safer and selective targeting of AML
2023 Perriello, V; Rotiroti, M; Pisani, I; Galimberti, S; Alberti, G; Pianigiani, G; Ciaurro, V; Marra, A; Sabino, M; Tini, V; Spinozzi, G; Mezzasoma, F; Morena, F; Martino, S; Salerno, D; Ashby, J; Wingham, B; Serafini, M; Martelli, M; Falini, B; Biondi, A; Tettamanti, S
Engineering tandem CD33xCD146 CAR CIK (cytokine-induced killer) cells to target the acute myeloid leukemia niche
2023 Alberti, G; Arsuffi, C; Pievani, A; Salerno, D; Mantegazza, F; Dazzi, F; Biondi, A; Tettamanti, S; Serafini, M
An in vivo humanized model to study homing and sequestration of Plasmodium falciparum transmission stages in the bone marrow.
2023 Donsante, S; Siciliano, G; Ciardo, M; Palmisano, B; Messina, V; de Turris, V; Farinacci, G; Serafini, M; Silvestrini, F; Corsi, A; Riminucci, M; Alano, P
Selective homing of CAR-CIK cells to the bone marrow niche enhances control of the Acute Myeloid Leukemia burden
2023 Biondi, M; Tettamanti, S; Galimberti, S; Cerina, B; Tomasoni, C; Piazza, R; Donsante, S; Bido, S; Maria Perriello, V; Broccoli, V; Doni, A; Dazzi, F; Mantovani, A; Dotti, G; Biondi, A; Pievani, A; Serafini, M
AML alters bone marrow stromal cell osteogenic commitment via Notch signaling
2023 Tomasoni, C; Arsuffi, C; Donsante, S; Corsi, A; Riminucci, M; Biondi, A; Pievani, A; Serafini, M
A Question of Frame: The Role of the Bone Marrow Stromal Niche in Myeloid Malignancies
2023 Tomasoni, C; Pievani, A; Rambaldi, B; Biondi, A; Serafini, M
Improving Bone Marrow Homing and Persistence of CD33.CAR-CIK Cells By Overexpression of a Gain-of-Function Variant of CXCR4 to Increase Efficacy in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Ingegnerizzazione di cellule CD33.CAR-CIK con una variante gain-of-function del recettore CXCR4 per aumentarne migrazione e persistenza nella nicchia midollare
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
GsαR201C and estrogen reveal different subsets of bone marrow adiponectin expressing osteogenic cells
2022 Palmisano, B; Labella, R; Donsante, S; Remoli, C; Spica, E; Coletta, I; Farinacci, G; Dello Spedale Venti, M; Saggio, I; Serafini, M; Robey, P; Corsi, A; Riminucci, M
MPSI Manifestations and Treatment Outcome: Skeletal Focus
2022 De Ponti, G; Donsante, S; Frigeni, M; Pievani, A; Corsi, A; Bernardo, M; Riminucci, M; Serafini, M
Safe and effective off-the-shelf immunotherapy based on CAR.CD123-NK cells for the treatment of acute myeloid leukaemia
2022 Caruso, S; De Angelis, B; Del Bufalo, F; Ciccone, R; Donsante, S; Volpe, G; Manni, S; Guercio, M; Pezzella, M; Iaffaldano, L; Silvestris, D; Sinibaldi, M; Dicecca, S; Pitisci, A; Velardi, E; Merli, P; Algeri, M; Lodi, M; Paganelli, V; Serafini, M; Riminucci, M; Locatelli, F; Quintarelli, C
CXCR4-MODIFIED CD33.CAR-CIK WITH ENHANCED BONE MARROW HOMING IN ACUTE MYELOID LEUKEMIA
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Overexpression of CXCR4 Enhances the Efficacy of CAR-T Therapy for Acute Myeloid Leukemia
2022 Biondi, M; Galimberti, S; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
CXCR4-modified CD33.CAR-CIK with enhanced bone marrow homing in Acute Myeloid Leukemia
2022 Biondi, M; Cerina, B; Tomasoni, C; Dotti, G; Tettamanti, S; Biondi, A; Pievani, A; Serafini, M
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile